Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue.
From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...